Form D · Biotechnology
Kings Royal Biotech Inc.
Bardwell, KY · CIK 0001735847
Offering snapshot reported Mar 30, 2018 · SEC filing
- Reported sold
- $750K Offering amount: $29.5M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 15, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 30, 2018 | Initial | $750,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-309030
Source: Form D, filed Mar 30, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kenneth Gordon Kohlenberger | Director |
| Robert Powell Porcella | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2350 Us Highway 51 N.
Bardwell, KY, 42023
Bardwell, KY, 42023